Pharmacist Clinical Delivery Services by State

Sources for Flu & Strep Maps:NASPA, Ability of Community Pharmacists to Independently Perform CLIA-waived Testing – A multistate legal review

The data in the tables was collected between May 19, 2023, and May 30, 2023. It is possible for the data to have changed since then. It is always best to confirm with your state government whether a pharmacist has prescribing authority and, if so, what type of authority (direct vs. CPA).

This is an ever-evolving landscape. Some states have proposed legislation at various stages, including some that have recently passed and are reflected in our data and disagree with our primary sources due to the date of publication of those sources.

Test-to-Treat data indicates jurisdictions that allow a pharmacist to independently perform CLIA-waived testing.

Not all provider status is equal and may vary in the scope of services covered under the medical benefit, the qualifications of eligible pharmacists and the pharmacist services sites eligible to participate in medical benefits. Legislation and regulation impacting pharmacist provider status is rapidly changing and many new concepts have been introduced in current state legislative sessions. As such, this map may have gaps related to recent changes.

Yes: Pharmacists have direct prescribing authority OR they have delegated prescribing authority/Collaborative Practice Agreements (CPA).

No: Pharmacists do not have prescribing authority.

Test: Pharmacists have direct prescribing authority OR they have delegated prescribing authority/Collaborative Practice Agreements (CPA). It might also mean they can only perform testing rather than test-to-treat.

Proposed: Legislation or bill under consideration by a legislature.

Unclear: The policy is vague or not defined for the respective state.

Silent: The respective state has not announced any intention of policy change.